Biomolecular Pathogenesis of Borderline Ovarian Tumors: Focusing Target Discovery Through Proteogenomics

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|1|107-116

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.1, 2010-02, pp. : 107-116

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hedgehog Signaling Pathway as Genetic and Epigenetic Target in Ovarian Tumors

By  

Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. : 73-94

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs that target pathogenesis of psoriasis

By  

Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Drug Discovery and Target Validation

By  

Cells Tissues Organs, Vol. 169, Iss. 3, 2001-06 ,pp. : 265-271

Karger

Access to resources Recommend Favorite

Biomolecular Interaction Analysis in Drug Discovery Using Surface Plasmon Resonance Technology

By  

Current Pharmaceutical Design, Vol. 12, Iss. 31, 2006-11 ,pp. : 3999-4021

Bentham Science Publishers

Access to resources Recommend Favorite

Drug target discovery using retroviruses

By Blø Magnus   Micklem David R   Lorens James B  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1285-1300

Informa Healthcare

Access to resources Recommend Favorite